Coronavirus Disease 2019 Messenger RNA Vaccines Associated With Delayed Onset of Breakthrough Infections and Fewer Radiographic Abnormalities

Xin Li, Jacky Man Chun Chan, Bosco Lam, David Christopher Lung, Kwok Cheung Lung, Christina Kin Yi Chow, Tracey Tam, Kelvin Hei Yeung Chiu, Ling Lung Hung, Ivan Fan Ngai Hung, Vincent Chi Chung Cheng, Kelvin Kai Wang To, Kwok Yung Yuen

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

This retrospective study of incoming travelers with coronavirus disease 2019 showed that individuals immunized by messenger RNA vaccines had significantly longer postvaccination intervals (median, 30.5 days) to breakthrough infection, lower white blood cell counts and lactate dehydrogenase levels on admission, and fewer radiographic abnormalities than those immunized by inactivated virus vaccine, who paradoxically had lower respiratory viral load.

Original languageEnglish
Pages (from-to)E905-E908
JournalClinical Infectious Diseases
Volume75
Issue number1
DOIs
Publication statusPublished - Jul 1 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.

ASJC Scopus Subject Areas

  • Microbiology (medical)
  • Infectious Diseases

Keywords

  • COVID-19
  • inactivated whole-virus vaccine
  • mRNA vaccine
  • vaccine breakthrough infection

Cite this